Evidence map›Paper›PMID 7809146›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America1994

Control of autoantibody affinity by selection against amino acid replacements in the complementarity-determining regions.

M Børretzen, I Randen, E Zdárský, O Førre, J B Natvig, K M Thompson

Abstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 1994. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed.

  1. Article
  2. Is Tolerance Broken in Autoimmunity?Clinical medicine insights. Pathology · 2017
    Article
  3. Article
  4. Use of similar immunoglobulin VH gene segments by MALT lymphomas of the ocular adnexa.Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc · 2009
    Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Peripheral deletion of rheumatoid factor B cells after abortive activation by IgG.Proceedings of the National Academy of Sciences of the United States of America · 1997
    Article
  14. Article
  15. Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

M BørretzenInstitute of Immunology and Rheumatology, Oslo, Norway.
I Randen
E Zdárský
O Førre
J B Natvig
K M Thompson

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Rheumatoid factor (RF) autoantibodies can be produced in healthy individuals after infections or immunizations and thus escape normal tolerization mechanisms. It has not been clear whether such autoantibodies can undergo somatic hypermutation and affinity maturation similar to antibodies to exogenous antigens. We have investigated how these autoantibodies are regulated in normal individuals by analyzing the sequences of monoclonal IgM RFs obtained as hybridomas from donors after immunization. The variable regions undergo extensive hypermutation, but in contrast to antibodies against exogenous antigens, there is a strong selection against mutations that result in replacement of amino acids in the hypervariable, or complementarity-determining, regions. Furthermore, we found no increase in affinity of these RFs with the accumulation of mutations. This suggests that high-affinity variants are tolerized during the hypermutation process and there is a peripheral mechanism operating on certain autoreactive B cells that, while not deleting or anergizing all autoreactive cells, prevents the generation of high-affinity autoantibodies. Comparison of RFs by using the VH1 DP-10 heavy chain variable region segment from both normal individuals and rheumatoid arthritis (RA) patients suggests that RF from RA patients may not be subject to such a controlling mechanism.

Indexed as

Antibody AffinityArthritis, RheumatoidBase SequenceDNA PrimersFemaleGenes, ImmunoglobulinHumansHybridomasImmunoglobulin Heavy ChainsImmunoglobulin MImmunoglobulin Variable RegionMolecular Sequence DataMutationRheumatoid FactorStructure-Activity RelationshipDNA PrimersImmunoglobulin Heavy ChainsImmunoglobulin MImmunoglobulin Variable RegionRheumatoid Factor

Identifiers

PMID7809146
PMCPMC45551

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.